Joachim Koch

Joachim Koch

Company: Affimed

Job title: VP of Translational Biology


Harnessing Innate Cell Engagers (ICE®) As Mono- & Combination Therapy to Induce Innate Immune Cell-Mediated Tumour Elimination with Favourable Safety Profiles 2:30 pm

Outlining the mechanism behind Affimed’s innate cell engagers and their ability to tailor therapies to specific patient populations Showcasing clinical data from the lead candidate AFM13 in combination with cord blood-derived NK cells in patients with r/r CD30-positive lymphoma Providing phase 1 trial data on AFM24 in solid tumours and discussing the potential for combination…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.